Results 11 to 20 of about 32,721 (222)

Meningococcal disease

African Journal of Emergency Medicine, 2011
The first cases of meningococcal meningitis were described in Geneva in 1805 and in New England in 1806, the causative agent finally being identified by Anton Weichselbaum in 1887.
Alex Koyfman, James Kimo Takayesu
doaj   +4 more sources

Preventing Meningococcal Disease in US Adolescents and Young Adults Through Vaccination [PDF]

Infectious Diseases and Therapy
In 2022, experts convened under the name Advancing Strategies to Prevent Meningococcal Disease (ARTEMIS) to gather insights on issues related to invasive meningococcal disease (IMD) and meningococcal vaccination in the US. Discussions regarding successes,
Jessica Presa, Ruth Carrico, Jaime E. Fergie, Stephanie Hanenberg, Gary S. Marshall, Kaitlyn Rivard, Jana Shaw, Gregory D. Zimet, Paula Peyrani, Alejandro Cane   +9 more
doaj   +2 more sources

Meningococcal disease serogroup C

Risk Management and Healthcare Policy, 2012
Félix O Dickinson1, Antonio E Pérez1, Iván E Cuevas21Department of Epidemiology, “Pedro Kourí” Institute, Havana, Cuba; 2Pharmacovigilance Group, Finlay Institute, Havana, CubaAbstract ...
Cuevas IE, Pérez AE, Dickinson FO   +2 more
doaj   +1 more source

Meningococcal disease: changes in epidemiology and prevention

Clinical Epidemiology, 2012
Qiuzhi Chang,1 Yih-Ling Tzeng,2 David S Stephens1–31Department of Epidemiology, Rollins School of Public Health, Emory University, 2Department of Medicine, Emory University School of Medicine, 3Laboratories of Microbial Pathogenesis, Department
Chang Q, Tzeng YL, Stephens DS
doaj   +1 more source

Epidemiological Characteristics of Meningococcal Infection in Moscow

Эпидемиология и вакцинопрофилактика, 2020
Aims. The purpose of this study was to identify current epidemiological features of meningococcal infection in Moscow.Materials and methods. Cases of invasive meningococcal disease in Moscow from 2014 to 2018 and the biomaterial from patients with an ...
M. I. Gritsay, M. A. Koroleva, N. N. Fomkina, I. S. Koroleva   +3 more
doaj   +1 more source

Proceedings of the Expert Consensus Group meeting on meningococcal serogroup B disease burden and prevention in India

Human Vaccines & Immunotherapeutics, 2022
Meningococcal disease is highly transmissible, life-threatening and leaves significant sequelae in survivors. Every year, India, which has a plethora of risk factors for meningococcal disease, reports around 3000 endemic cases.
Anand P. Dubey, Rashna Dass Hazarika, Veronique Abitbol, Shafi Kolhapure, Someya Agrawal   +4 more
doaj   +1 more source

The association of meningococcal disease with influenza in the United States, 1989-2009. [PDF]

PLoS ONE, 2014
Prior influenza infection is a risk factor for invasive meningococcal disease. Quantifying the fraction of meningococcal disease attributable to influenza could improve understanding of viral-bacterial interaction and indicate additional health benefits ...
Jessica Hartman Jacobs, Cécile Viboud, Eric Tchetgen Tchetgen, Joel Schwartz, Claudia Steiner, Lone Simonsen, Marc Lipsitch   +6 more
doaj   +1 more source

Meningococcal disease in one soldier patient: case report from Vietnam

Vietnam Journal of Science, Technology and Engineering, 2021
Meningococcal disease is caused by an infection with Neisseria meningitidis (N. meningitidis) bacteria, which is responsible for two major forms of the disease including meningitis and/or septicaemia. N.
Nguyen Thanh Viet, Nguyen Minh Nam, Nguyen Vu Trung, Do Tuan Anh, Hoang Van Tong   +4 more
doaj   +1 more source

Summary of the NACI Statement on the Use of Bivalent Factor H Binding Protein Meningococcal Serogroup B (MenB-fHBP) Vaccine for the Prevention of Meningococcal B Disease

Canada Communicable Disease Report, 2020
Background: Trumenba™, a bivalent, factor-H binding protein meningococcal serogroup B (MenB-fHBP) vaccine was authorized for use in Canada in October 2017 for the prevention of invasive meningococcal disease (IMD) caused by Neisseria meningitidis ...
Robyn Harrison, Robert Stirling, Oliver Baclic, Wendy Vaudry   +3 more
doaj   +1 more source

Current status and challenges of meningococcal vaccines development in China

Zhongguo gonggong weisheng, 2022
Vaccination is the most effective and economical way to prevent meningococcal meningitis. In the past few decades, with widespread use of meningococcal vaccines, the incidence of meningococcal meningitis has dropped significantly. There are some vaccines
Ying-hua XU, Ya-nan LI, Qiang YE
doaj   +1 more source